Psych News Alert | Johnson and Johnson

Johnson & Johnson to Pay More Than $2 Billion in Risperdal Marketing Case

Nov 5, 2013 12:00:00 AM

Pharmaceutical firm Johnson & Johnson (J&J) and its subsidiaries will pay more than $2.2 bil...

Arkansas Jury Finds Johnson & Johnson Guilty in Latest Risperdal Case

Apr 12, 2012 12:00:00 AM

Johnson & Johnson (J&J) "lied to patients and doctors" in its claims about its antipsychotic...